U.S. FDA approves twice yearly shot to prevent HIV transmission
The U.S. Food and Drug Administration has approved a drug called lenacapavir — a twice-a-year shot to protect against HIV infection. Experts say the preventative medication brings the possibility of ending HIV transmission.